Carrie Harney, JD, of US Pharmacopeia (USP) discusses how proposed tariffs could impact generic drug supply chains, sterile injectable shortages, and pharmacy operations, underscoring the need for policy incentives and manufacturing diversification.
Carrie Harney, JD
Advertisement
Articles by Carrie Harney, JD
Advertisement
Latest Updated Articles
USP Expert Discusses Balancing Drug Cost, Quality, and Access in a Changing Trade LandscapePublished: July 23rd 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Therapeutic Cancer Vaccines: Are We There Yet?
2
In the Fragmented Landscape of Long COVID Care, Pharmacists Are Essential
3
Amivantamab Shows 45% Response Rate in Pretreated Head and Neck Cancer: OrigAMI-4 Findings
4
FDA Approves Gazyva for Active Lupus Nephritis
5
